1. Home
  2. JHX vs VTRS Comparison

JHX vs VTRS Comparison

Compare JHX & VTRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo James Hardie Industries plc (Ireland)

JHX

James Hardie Industries plc (Ireland)

HOLD

Current Price

$19.98

Market Cap

11.8B

Sector

Industrials

ML Signal

HOLD

Logo Viatris Inc.

VTRS

Viatris Inc.

HOLD

Current Price

$10.94

Market Cap

12.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JHX
VTRS
Founded
1888
1961
Country
Ireland
United States
Employees
N/A
N/A
Industry
Building Materials
Medicinal Chemicals and Botanical Products
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.8B
12.0B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
JHX
VTRS
Price
$19.98
$10.94
Analyst Decision
Strong Buy
Hold
Analyst Count
9
6
Target Price
$28.60
$11.17
AVG Volume (30 Days)
6.6M
7.9M
Earning Date
11-17-2025
11-06-2025
Dividend Yield
N/A
4.39%
EPS Growth
N/A
N/A
EPS
0.40
N/A
Revenue
$4,116,899,999.00
$14,124,400,000.00
Revenue This Year
$24.54
N/A
Revenue Next Year
$15.32
$1.16
P/E Ratio
$59.44
N/A
Revenue Growth
4.60
N/A
52 Week Low
$16.46
$6.85
52 Week High
$29.83
$13.13

Technical Indicators

Market Signals
Indicator
JHX
VTRS
Relative Strength Index (RSI) 58.78 60.39
Support Level $19.14 $10.67
Resistance Level $19.90 $10.93
Average True Range (ATR) 0.57 0.24
MACD 0.31 0.01
Stochastic Oscillator 97.74 90.23

Price Performance

Historical Comparison
JHX
VTRS

About JHX James Hardie Industries plc (Ireland)

James Hardie is a manufacturer of fiber cement-based building products, selling primarily to the residential construction industry. North America is the primary geography, generating about 80% of group earnings. Here, it is the largest manufacturer of fiber cement, which is mainly used for exterior siding on houses. Following the Azek acquisition in 2025, it also produces wooden composite decking materials, siding trims, and accessories for outdoor areas including stair and deck railing. Businesses in Australia, New Zealand, and Europe, make up the rest of earnings.

About VTRS Viatris Inc.

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. The remaining 60% of sales are derived from its portfolio of legacy products, which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

Share on Social Networks: